Literature DB >> 11720441

SYT-SSX fusion genes and prognosis in synovial sarcoma.

A Mezzelani1, L Mariani, E Tamborini, V Agus, C Riva, S Lo Vullo, A Fabbri, M Stumbo, A Azzarelli, P G Casali, A Gronchi, G Sozzi, M A Pierotti, S Pilotti.   

Abstract

A case series of 64 synovial sarcomas was characterized for the SYT-SSX fusion transcripts and statistically analysed in order to correlate molecular data with prognosis and morphology. SYT-SSX1 fusion transcript appeared to be an independent, though not reaching statistical significance (P = 0.183), prognostic factor clearly associated with a reduced metastasis-free survival. Regarding the association between transcript type and histologic subtype we found, a borderline P value (P = 0.067) between the SYT-SSX1 transcript and the biphasic subtype which, subsequently expanding the analysis to 70 cases, turned out to be significant. However, we could not confirm the prediction value of the biphasic subtype for the presence of the SYT-SSX1 transcript since in our hands 6 out 33 (18%) biphasic tumours carried the SYT-SSX2 transcript.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11720441      PMCID: PMC2363950          DOI: 10.1054/bjoc.2001.2088

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  19 in total

1.  SYT-SSX fusion transcripts and epithelial differentiation in synovial sarcoma.

Authors:  A Mezzelani; G P Dagrada; G Sozzi; M A Pierotti; S Pilotti
Journal:  Diagn Mol Pathol       Date:  2000-12

2.  The SYT-SSX1 variant of synovial sarcoma is associated with a high rate of tumor cell proliferation and poor clinical outcome.

Authors:  G Nilsson; B Skytting; Y Xie; B Brodin; R Perfekt; N Mandahl; J Lundeberg; M Uhlén; O Larsson
Journal:  Cancer Res       Date:  1999-07-01       Impact factor: 12.701

3.  Association of SYT-SSX fusion types with proliferative activity and prognosis in synovial sarcoma.

Authors:  H Inagaki; T Nagasaka; T Otsuka; E Sugiura; N Nakashima; T Eimoto
Journal:  Mod Pathol       Date:  2000-05       Impact factor: 7.842

4.  Analysis of SYT-SSX fusion transcripts and bcl-2 expression and phosphorylation status in synovial sarcoma.

Authors:  T Mancuso; A Mezzelani; C Riva; A Fabbri; L Dal Bo; G Sampietro; P Perego; P Casali; F Zunino; G Sozzi; M A Pierotti; S Pilotti
Journal:  Lab Invest       Date:  2000-06       Impact factor: 5.662

5.  Strong association of SYT-SSX fusion type and morphologic epithelial differentiation in synovial sarcoma.

Authors:  C R Antonescu; A Kawai; D H Leung; F Lonardo; J M Woodruff; J H Healey; M Ladanyi
Journal:  Diagn Mol Pathol       Date:  2000-03

6.  Synovial sarcoma--identification of favorable and unfavorable histologic types: a Scandinavian sarcoma group study of 104 cases.

Authors:  B Skytting; J M Meis-Kindblom; O Larsson; M Virolainen; R Perfekt; M Akerman; L G Kindblom
Journal:  Acta Orthop Scand       Date:  1999-12

7.  Synovial sarcoma: a multivariate analysis of prognostic factors in 112 patients with primary localized tumors of the extremity.

Authors:  J J Lewis; C R Antonescu; D H Leung; D Blumberg; J H Healey; J M Woodruff; M F Brennan
Journal:  J Clin Oncol       Date:  2000-05       Impact factor: 44.544

8.  Prognostic significance of nuclear accumulation of c-myc and mdm2 proteins in synovial sarcoma of the extremities.

Authors:  J Shen; K Scotlandi; N Baldini; M C Manara; S Benini; V Cerisano; P Picci; M Serra
Journal:  Oncology       Date:  2000-04       Impact factor: 2.935

9.  Tendosynovial sarcoma. Clinicopathologic features, treatment, and prognosis.

Authors:  J T Brodsky; M E Burt; S I Hajdu; E S Casper; M F Brennan
Journal:  Cancer       Date:  1992-07-15       Impact factor: 6.860

10.  c-KIT and c-KIT ligand (SCF) in synovial sarcoma (SS): an mRNA expression analysis in 23 cases.

Authors:  E Tamborini; D Papini; A Mezzelani; C Riva; A Azzarelli; G Sozzi; M A Pierotti; S Pilotti
Journal:  Br J Cancer       Date:  2001-08-03       Impact factor: 7.640

View more
  10 in total

Review 1.  Molecular and clinicopathological findings in a tonsillar synovial sarcoma. A case study and review of the literature.

Authors:  U Vogel; M Wehrmann; W Eichhorn; B Bültmann; M Stiegler; W Wagner
Journal:  Head Neck Pathol       Date:  2010-07-13

2.  Synovial sarcoma in patients under 20 years of age: a multicenter study with a minimum follow-up of 10 years.

Authors:  Bernhard M Speth; Andreas H Krieg; Andre Kaelin; G Ulrich Exner; Louis Guillou; Arthur von Hochstetter; Gernot Jundt; Fritz Hefti
Journal:  J Child Orthop       Date:  2011-08-11       Impact factor: 1.548

Review 3.  Gene translocations in musculoskeletal neoplasms.

Authors:  Balaji Krishnan; Gaurav Khanna; Denis Clohisy
Journal:  Clin Orthop Relat Res       Date:  2008-06-20       Impact factor: 4.176

Review 4.  Sarcoma molecular testing: diagnosis and prognosis.

Authors:  Alexander J F Lazar; Jonathan C Trent; Dina Lev
Journal:  Curr Oncol Rep       Date:  2007-07       Impact factor: 5.075

5.  Expression of FGFR3 and FGFR4 and clinical risk factors associated with progression-free survival in synovial sarcoma.

Authors:  Bridget Charbonneau; Rachel Isaksson Vogel; J Carlos Manivel; Anthony Rizzardi; Stephen C Schmechel; Simona Ognjanovic; Subbaya Subramanian; David Largaespada; Brenda Weigel
Journal:  Hum Pathol       Date:  2013-05-10       Impact factor: 3.466

6.  Recurrent and novel SS18-SSX fusion transcripts in synovial sarcoma: description of three new cases.

Authors:  Joanna Przybyl; Raf Sciot; Piotr Rutkowski; Janusz A Siedlecki; Vanessa Vanspauwen; Ignace Samson; Maria Debiec-Rychter
Journal:  Tumour Biol       Date:  2012-09-14

7.  The clinical implication of SS18-SSX fusion gene in synovial sarcoma.

Authors:  T Ren; Q Lu; W Guo; Z Lou; X Peng; G Jiao; Y Sun
Journal:  Br J Cancer       Date:  2013-09-10       Impact factor: 7.640

8.  Genomic complexity in pediatric synovial sarcomas (Synobio study): the European pediatric soft tissue sarcoma group (EpSSG) experience.

Authors:  Daniel Orbach; Véronique Mosseri; Daniel Pissaloux; Gaelle Pierron; Bernadette Brennan; Andrea Ferrari; Frederic Chibon; Gianni Bisogno; Gian Luca De Salvo; Camille Chakiba; Nadège Corradini; Véronique Minard-Colin; Anna Kelsey; Dominique Ranchère-Vince
Journal:  Cancer Med       Date:  2018-03-13       Impact factor: 4.452

9.  Prognostic value of SS18-SSX fusion type in synovial sarcoma; systematic review and meta-analysis.

Authors:  Tadahiko Kubo; Shoji Shimose; Jun Fujimori; Taisuke Furuta; Mitsuo Ochi
Journal:  Springerplus       Date:  2015-07-25

10.  The impact of chromosomal translocation locus and fusion oncogene coding sequence in synovial sarcomagenesis.

Authors:  K B Jones; J J Barrott; M Xie; M Haldar; H Jin; J-F Zhu; M J Monument; T L Mosbruger; E M Langer; R L Randall; R K Wilson; B R Cairns; L Ding; M R Capecchi
Journal:  Oncogene       Date:  2016-03-07       Impact factor: 9.867

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.